![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 50, 48558-48564, December 13, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,From the Digestive Health Center of Excellence, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908
Received for publication, July 1, 2002, and in revised form, September 17, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Regulation of messenger RNA stability by AU-rich
elements is an important means of regulating genes induced by growth
factors and cytokines. Nup475 (also known as tristetraprolin, or TIS11) is the prototype for a family of zinc-binding Cys3His
motif proteins required for proper regulation of tumor necrosis factor
mRNA stability in macrophages. We developed an Escherichia
coli expression system to produce soluble Nup475 protein in
quantity to study its RNA binding properties. Nup475 protein bound a
tumor necrosis factor AU-rich element over a broad range of pH and salt
concentrations by RNA gel shift. This binding was inhibited by excess
zinc metal, providing a potential mechanism for previous reports of
zinc stabilization of AU-rich element (ARE) containing messenger RNAs.
Immobilized Nup475 protein was used to select its optimal binding site
by RNA SELEX and revealed a strong preference for the extended sequence UUAUUUAUU, rather than a simple AUUUA motif. These findings were confirmed by site-directed mutagenesis of the tumor necrosis factor ARE
and RNA gel shifts on c-fos, interferon- Regulation of eukaryotic messenger RNA stability is an important
factor in controlling gene expression (1). The AU-rich element
(ARE)1 is a critical
regulatory motif in the 3' untranslated regions of many cytokine and
protooncogene mRNAs, a target for proteins that bind and alter RNA
kinetics. Although there has been some debate regarding the optimal
sequence length for the ARE (5 versus 9 base pairs) (2, 3),
these sites are a target for an increasing number of RNA-binding
proteins that serve either to stabilize or destabilize the messenger
RNAs containing these elements.
Nup475 was originally cloned as part of an early G1 genetic
program of mRNA expression in response to serum and mitogenic growth factors (4), co-expressed with the protooncogenes
c-fos, c-jun, and c-myc (4, 5). Also
known as tristetraprolin (6) (and TIS11 (7)), this protein is an
important regulator of tumor necrosis factor expression in macrophages
(8). A targeted deletion of the murine gene created a syndrome of tumor
necrosis factor overload due to increased TNF mRNA stability (9).
The TNF destabilizing activity was mapped to the two
Cys3His domains in transfection and immunoprecipitation
experiments (10). The Cys3His domain is a zinc-binding
domain in a different structural family from the zinc finger, although
both domains require a coordinated zinc metal for stability (11).
Forced overexpression of this cDNA or other family members (TIS11b,
TIS11d) with closely conserved Cys3His domains leads to
apoptotic death of fibroblasts (12).
To determine the specificity of Nup475 in AU-rich element regulation,
we pursued an analysis of the Nup475/TIS11/tristetraprolin protein-RNA
interaction using recombinant protein. Published reports have relied
upon cell lines and immunoprecipitation to map the protein's RNA
target to a TNF fragment containing the AU-rich element (10) but have
not permitted a high resolution analysis of the protein's optimal
binding site. Although Escherichia coli-expressed protein
has been used in phosphorylation studies, we are unaware of any study
successfully using recombinant protein in studies of RNA binding. A
report questioning whether the protein requires an RNA target sequence
more extensive than a minimal ARE or requires phosphorylation for RNA
binding underscores the need to recover unmodified protein in quantity
so that these and other questions can be specifically addressed
(13).
In this manuscript, a system for high level E. coli
expression of Nup475 permitted characterization of the RNA binding
properties of this protein and identification of the consensus Nup475
binding site from a random RNA pool.
E. coli Protein Expression and Purification--
An in-frame
fusion of Nup475 and pGEX4T-1 (Amersham Biosciences) was created
by subcloning from a plasmid that contains Nup475 cDNA between
flanking NotI sites, creating GST-Nup475. The details of
this subcloning are available upon request. Plasmid pREP4-GroESL was
kindly provided by Martin Steiger (Hoffman-La Roche). All large scale
plasmid preparations were performed using the Qiagen Maxiprep kit.
The GST-Nup475 fusion protein plasmid was transformed into Rosetta
pLysS cells (Novagen, Madison, WI) and Rosetta pLysS/pREP4-GroESL cells. Electrocompetent Rosetta pLysS/pREP4-GroESL cells were created
after transformation with the pREP4-GroESL plasmid followed by
electroporation using an established protocol (14). Selection was
performed on LB plates or in liquid LB culture containing the
appropriate antibiotics. The bacteria were grown in liquid media to an
A600 nm on a Genequant Pro to 0.3-0.4,
where protein induction was induced with the addition of IPTG to 1 mM. Protein expression was verified with Coomassie-stained
Laemmli gels as previously described (11). Purification was performed over glutathione-Sepharose (Amersham Biosciences) using the
manufacturer's protocol followed by dialysis in three changes of 50 mM Tris, pH 8.0, 1 mM dithiothreitol,
and 100 µM ZnCl2 made with RNase-free water.
Protein concentration was performed using Amicon Centriplus YM-3
Centrifugal Concentrators. Final protein concentration was determined
using the Bradford Assay (Bio-Rad).
RNA Probe Synthesis--
Labeled RNA probes were synthesized
using radioactive [
After oligonucleotide annealing and RNA synthesis using the T7
Megashortscript manufacturer's protocol (Ambion) to make radioactive RNA probe, the reaction was phenol/chloroform/IAA- and
chloroform/IAA-extracted, and the aqueous phase spun through two
sequential Microspin G25 columns (Amersham Biosciences) to remove
unincorporated label.
RNA EMSA Analysis--
A standard Tris-borate buffer EMSA
protocol (15) was modified by the elimination of EDTA to avoid the
possibility of zinc chelation from Nup475 protein. Binding reactions
were performed at final concentrations of 20 mM HEPES, pH
7.2, 1 mM dithiothreitol, 50 mM KCl, 5%
glycerol, 2 µg/µl acetylated-bovine serum albumin, and 100 µM zinc chloride for 15 min at room temperature with
50,000 cpm of probe and 2 µg of recombinant protein per reaction,
unless otherwise indicated, shown in preliminary experiments to
represent an equilibrium condition. Binding reactions were resolved on
a 4% Tris-borate gel in 0.25× TB buffer (which had been pre-run for
30 min prior to loading), dried, and autoradiography performed. For the
pH titration, two solutions with the same buffer composition as above,
but at pH 5.5 and 8.5, respectively, were created. The range of pH
buffers was created by mixing these two buffers to create buffers that
were otherwise equivalent except for the pH value. The differing salt
concentrations were created by adding aliquots of RNase-free 2 M KCl to the binding buffer components.
For the verification of the SELEX isolates, miniprep DNA was used as a
template for PCR amplification, and phenol/chloroform-extracted, ethanol-precipitated DNA products were used as a template for RNA
production using the T7 Megashortscript kit (Ambion). GST-Nup475 was
compared with GST alone in RNA gel shift reactions as described.
RNA SELEX--
A T7 RNA polymerase generated pool of RNA
fragments using the T7 Megashortscript kit (Ambion)with a central
random 25-mer sequence was constructed by PCR as described (16). After
RNA synthesis, the DNA template was eliminated by incubation with 1 µl of RNase-free DNase I (Ambion) for 15 min at 37 °C, followed by
phenol extraction and column chromatography as noted above. Protein
immobilization, RNA binding, elution, and reverse
transcription-PCR was performed as described by Sakashita and
Sakamoto (16), except that the RNA-protein complex was washed with five
washes of RNA-EMSA buffer and the BamH1-digested PCR
products were 5% TBE PAGE gel-purified and cloned into BlueScript
KS( E. coli expression typically does not result in typical
eukaryotic posttranslational modifications including glycosylation and
phosphorylation (17). Given the questions regarding the minimal RNA
target site and the need for phosphorylation for RNA binding (13), an
E. coli-expressed recombinant protein is preferred. In Fig.
1A, a GST fusion did express a
limited amount protein of the predicted molecular mass
(asterisk), but the induced protein was in the insoluble fraction (not
shown). Our GST-Nup475 construct was similar to that in a previous
manuscript using a GST-Nup475 fusion (18). Although the details of
expression and purification are not provided in the prior report, in
our laboratory, high-level expression of properly folded Nup475 is not
a feature of standard E. coli protein expression
methods.
, and
interferon-
ARE fragments. A weaker binding activity toward
adenine-rich sites, such as a poly(A) tail RNA fragment, can partially
disrupt the Nup475-tumor necrosis factor AU-rich element complex.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]UTP for the TNF probes,
[
-32P]CTP for the TNF cytosine mutants, and
[
-32P]ATP for the poly(A)-like probes from
gel-purified, RNase-free confirmed oligonucleotides, which anneal to
form a T7 RNA polymerase site and a template for RNA synthesis. All
probes used the same upper oligonucleotide (AAT TTA AT ACG ACT CAC TAT
AGG). The lower oligonucleotides for the RNA probe synthesis include: a
murine TNF ARE (CAA GCA AAT AAA TAA ATA AAG TGC CCT ATA GTG AGT
CGT ATT AAA TT); mutant TNF ARE sites flanked by CCC, which encode five (CAA GCA AAG GGT AAA TGG GAA ATA AAG TGC CCT ATA GTG AGT
CGT ATT AAA TT), seven (CAA GCA AGG GAT AAA TAG GGA ATA AAG
TGC CCT ATA GTG AGT CGT ATT AAA TT), and 9 base pair ARE sequences (CAA
GCA GGG AAT AAA TAA GGG ATA AAG TGC CCT ATA GTG AGT CGT ATT
AAA TT). Other template (lower) oligonucleotides for RNA probe
synthesis include: the murine TNF polyadenylation addition signal (plus flanking residues; TTT TTT TTT CTT TTC CAA GCG ATC TTT ATT TCT CTC AAC
CCT ATA GTG AGT CGT ATT AAA TT), a poly(A) tail (TTT TTT TTT TTT TTT
TTT TTT TTT TCC CTA TAG TGA GTC GTA TTA AAT T), the murine
c-fos coding region determinant (CCT TCG GAT TCT CCT TTT CTC
TTC TTC TTC TGG AGA TCC TAT AGT GAG TCG TAT TAA ATT), the mouse
c-fos ARE (CCA TCT TAA TAA ATA AAT TGA AAC CCT ATA GTG AGT CGT ATT AAA TT), the human interferon-
ARE (CCA TAT AAA TAA TGT TAA
ATA TTC CCT ATA GTG AGT CGT ATT AAA TT) and the human inteferon-
ARE
(TAA AAT TTA AAT AAA TAA AAA TAA CCC TAT AGT GAG TCG TAT TAA ATT).
). Insert-containing plasmid clones were evaluated by
dye-terminator DNA sequencing using primers flanking the insert on a
PerkinElmer Life Sciences/ABI 377.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (42K):
[in a new window]
Fig. 1.
Nup475/tristetraprolin/TIS-11
production in E. coli expression requires the
GroESL chaperone. In A, E. coli lysates of a
GST-Nup475 fusion at 0 and 4 h after
isopropyl-1-thio-
-D-galactopyranoside induction were run
on a 10% Laemmli electrophoresis gel and stained with Coomassie R250.
The GST fusion is weakly induced at the expected molecular mass (*),
but was expressed in the insoluble fraction (not shown). In
B, co-induction of the GST fusion with a GroESL plasmid led
to an increase in protein production. Solubility testing of the
bacterial lysates revealed the predominance of this protein in the
soluble fraction (not shown), which was purified to homogeneity over a
glutathione-Sepharose column (C).
Eukaryotic expression systems have the benefits of eukaryotic
chaperones to facilitate protein folding. We attempted high-level expression of Nup475 in a variety of yeast, baculovirus, and mammalian expression systems, but obtained expression levels that were trivial compared with those customarily seen in these systems (not shown). Our
assumption regarding a relative lack of chaperone activity in E. coli was tested by adding a plasmid that overexpresses the E. coli GroES/EL chaperone complex at the time of protein
induction, a method useful for expression of eukaryotic proteins that
were otherwise insoluble in E. coli (19, 20). We transformed
our GST-Nup475 fusion plasmid into RosettapLysS cells (Novagen) with a
well characterized GroES/EL expression plasmid and induced protein synthesis with isopropyl-1-thio-
-D-galactopyranoside. In
Fig. 1B, the GST fusion protein expresses at its predicted
molecular mass (near that of GroEL) and is found in the soluble
fraction (not shown). This approach allowed purification of the
GST-Nup475 protein over a glutathione-Sepharose column to homogeneity
(Fig. 1C), up to 30-50 mg/liter of culture.
Determining whether or not the soluble protein was functional required an analysis of a known Nup475 RNA target, such as the tumor necrosis factor AU-rich element, in an assay for a protein-RNA interaction. As a first test, we used a relatively short motif from the TNF 3'-UTR, reasoning from the structures of other zinc-binding motifs that the two Cys3His motifs in the protein's RNA binding domain would not bind more than one AUUUA each. This rationalization extends from RNA folding experiments in our laboratory that show the TNF and granulocyte-macrophage colony-stimulating factor AREs in bubbles and other unstructured single stranded regions (not shown) and structures of other zinc-containing motifs on nucleic acid targets. For instance, in the Zif268 crystal structure, each zinc finger contacts three nucleotides of the DNA recognition site (21). These findings would also have later implications for our ultimate plan to select consensus binding sites using immobilized protein since the use of short random RNA fragments would simplify analysis (SELEX) (16), as opposed to a library of larger native 3'-UTR fragments (22). The latter case would require more detailed mapping experiments to find the precise binding site. The ability to select sites by SELEX alone does not preclude a secondary structural element requirement for functional activity: for the AU-rich element binding Apobec-1 protein, SELEX-selected sites were found to reside on one face of a higher ordered structure in the c-myc 3'-UTR (23).
A short single-stranded TNF RNA probe was used for RNA-protein
interaction studies by EMSA, shown in Fig.
2A. Recombinant GST and
GST-Nup475 were incubated with the probe to determine if the
recombinant protein was capable of RNA binding. The unmodified recombinant GST-Nup475 protein binds RNA; no shifted band is seen with
GST alone.
|
Previous work revealed that Nup475 had apoptosis-promoting activity when heterologously overexpressed in NIH3T3 fibroblasts (12). Nup475 mRNA is expressed as part of the apoptotic cell death program in PC12 cells (24), although the functional significance of this finding is unknown. If this protein retains its RNA binding activity during apoptosis, we hypothesized that it should have the ability to perform its function over a broad range of physico-chemical conditions. Apoptosis triggers a fall in intracellular pH associated with activation of cytosolic caspases (25). Protonation of coordinating residues in the Nup475 first Cys3His repeat leads to a loss of the zinc cofactor and proper protein structure by NMR, so that lower pH values could lead to a loss of protein structure and therefore its function (11).2 A series of physiologic and supra-physiologic salt and pH conditions establish the robustness of Nup475 RNA binding shown in Fig. 2B.
Zinc is a necessary cofactor for the Nup475 Cys3His
domains, with the first motif having a dissociation constant for zinc of less than 10
11 at neutral pH (11). In cell culture,
zinc stabilizes ARE-containing RNAs such as Nup475 and c-fos
through a mechanism that inhibits RNA degradation (26) and also
prevents the effects of linoleic acid and TNF to promote apoptosis
in endothelial cell lines through an unknown mechanism (27). Metal
effects on RNA binding are well described: magnesium has been shown to
inhibit the binding of another ARE binding protein,
AUF1/hnRNPDo, to a TNF ARE probe (28). We hypothesized that
a possible mechanism for zinc stabilization of ARE-containing mRNAs
would be interference of RNA binding by an AU-rich element-binding
destabilizing protein, with Nup475 as a reasonable candidate. As shown
in Fig. 2C, administration of excess zinc to the RNA binding
reaction prevents formation of the Nup475-TNF ARE complex, suggesting
that zinc levels well above the picomolar amounts needed for the
Cys3His motif can modulate the binding of Nup475 to its
cognate RNA sequence. This effect was also seen with cobalt, a metal
used in biophysical studies as a spectrophotometric probe for zinc
(11), but not with manganese or magnesium (data not shown), which have
different ligand preferences in coordination complexes (29).
The general parameters of the Nup475 protein-RNA interaction developed in Fig. 2 were used as a foundation for determination of the optimal Nup475 binding site. A controversy in the literature has been the width of the minimal AU-rich element site, with evidence for both sufficient regulation from a 5 base pair AUUUA site and for a larger nonamer UUA UUU A(U/A)(U/A) site (2, 3). When these experiments were performed, the complexity of AU-rich elements and the number of ARE-binding proteins were not known, and the unwritten assumption was that a single protein targeted this RNA element. Other TNF 3'-UTR binding proteins such as TIA-1 (30), TIAR (30), and AUF-1/hnRNPDo (31) have been used to select RNA binding targets from a random pool, but none of these have identified a consensus sequence containing UUAUUUAUU or an AUUUA core.
A 25-mer random sequence with flanking known sequence (including the T7
RNA pol promoter) was constructed as described by Sakashita and
Sakamoto (16) three cycles of SELEX performed, with the selected
cDNA cloned into the BamH1 site of BlueScript KS(
).
Twenty-one clones were sequenced with the flanking sequences used to
determine the original selected RNA sequence.
Sixteen of the clones selected for sequences were similar to the
UUAUUUAUU sequence, six with an exact match for this sequence and eight
others differing by a single flanking residue (Fig. 3A). Five independent clones
representing three unique sequences formed the rest of those isolated
and are all adenine-rich (Fig. 3B). All of the isolated
clones (the 16 ARE-like and five adenine-rich) were verified to be
bound by the recombinant GST-Nup475 in RNA EMSA reactions using DNA
templates amplified from individual clones. A sample of these gel shift
reactions is shown in Fig. 3C, where samples 1,
4, and 5 represent ARE-like isolates and
2 and 3 represent adenine-rich isolates. These
adenine-rich clones all produced significantly less of a Nup475 shifted
band by EMSA as represented in the figure.
|
The aligned consensus sequence for the ARE-like sites, UUAUUUAUU, is represented as a histogram in Fig. 3D with the exact frequencies for each residue shown in the accompanying table. The binomial test was used to determine a "threshold" residue frequency of 50% (p < 0.05) for a given residue at a particular position based on the number of samples sequenced and the assumption that each of the four possible residues should be equally likely to occur at any given site (i.e. expected residue frequency = 25%). That is, if the observed frequency for a given residue at a particular position is greater than 50%, the residue was not likely to have occurred at this position by chance alone (p < 0.05). Thus, we are unable to statistically resolve the distinction between UUAUUUAUU or UUAUUUA(U/A)(U/A) using the binomial test, although the preference for sequences similar to these is quite clear.
To test the finding that the preferred Nup475 RNA binding site was more
than a simple AUUUA, we mutated the TNF ARE to add two pairs of
cytosine triplets on either side of the AU-rich element with different
spacing, creating RNA oligonucleotide cores which could be labeled to
the same specific activity, but representing 9, 7, and 5 base pairs of
the uninterrupted native sequence (core sequences CCC
UUAUUUAUU CCC, UCCC UAUUUAU CCCU, and
UUCCC AUUUA CCCUU, respectively). Four sets of
RNA EMSA reactions were run on the same gel with the same amount of
each probe, and the results quantified by PhosphorImager analysis (Fig.
4, A and B). A
clear preference for 9-base pair ARE motifs rather than the simple
AUUUA is demonstrated (p < 0.0001), with intermediate
binding to the 7-base pair element (p < 0.05). In Fig.
4C, the TNF ARE fragment is compared with short RNAs
containing AREs from murine c-fos (UUAUUUAUU), human
interferon-
ARE (AUAUUUAA and UUAUUUAUA in close proximity), and
human interferon-
(UUAUUUAUU).
|
Dual ARE and poly(A) tail RNA binding activities are described for the
RNA-stabilizing HuC protein (32) and other ELAV family members (33). An
unknown regulatory protein was described that could bind either the
interferon-
ARE or a poly(A) tail, but not both simultaneously (34).
Our five adenine-rich sites were compared with three other elements
known to be involved in RNA stability: a representative poly(A) tail
fragment, the TNF polyadenylation signal sequence, and the
c-fos coding region determinant. Fig. 5A shows the alignment of our
selected sequences to these motifs. In Fig. 5B, a gel shift
was performed comparing the TNF ARE RNA fragment to these known motifs.
A shifted band was seen only for the poly(A) fragment, although in Fig.
5C, addition of the unlabeled poly(A) RNA fragment to the
TNF ARE gel shift fails to produce a slower migrating complex, leading
to dimunition of the TNF complex. This is comparable to the previous
report for the interferon-
3'-UTR.
|
| |
DISCUSSION |
|---|
|
|
|---|
Our studies with Nup475 on a TNF AU-rich element fragment reveal much about the functional properties of this protein. The recombinant protein is capable of binding a short fragment of the TNF 3'-UTR without posttranslational modification over a broad range of pH and salt conditions. The increase in the shifted complex at the highest salt conditions suggests the importance of hydrophobic interactions in stabilizing this interaction. The sensitivity of this interaction to zinc concentrations suggests a possible mechanism for the previous report of zinc stabilization of AU-rich element-containing RNAs (26). Zinc also has been described to augment cytokine production from freshly isolated peripheral blood mononuclear cells through an unknown mechanism (35); zinc inhibition of Nup475-mediated destabilization is a potential mechanism for this.
Three rounds of SELEX revealed two sets of RNA binding sites. The AU-rich consensus is an exact consensus match for the 9-base pair ARE site functionally proposed for the c-fos protooncogene (2, 3) and makes Nup475 a candidate for its regulation, all of which is supported by our gel shift data. This was originally described by inspection as an 8-base pair consensus UUAUUUAU motif in the 3'-UTR of TNF, other cytokines, and protooncogenes (36). Both groups of investigators reporting the 9-base pair ARE found that the core UAUUUAU sequence was intolerant of mismatches in flanking residues, similar to our results with the cytosine-interposed TNF AU-rich element RNA probes. Whether c-fos mRNA and the Nup475 protein are part of a functional regulatory complex will require further study, although this could explain the co-expression of Nup475 as part of the early G1 response (4) as a mechanism for down-regulating these mRNAs prior to expression of late G1 genes and subsequent S phase (37). Removal of the c-fos ARE is sufficient to make the protooncogenic c-fos mRNA capable of transforming fibroblasts (38), underscoring the importance of this motif in preventing cell cycle dysregulation.
The second, less abundant group of isolated sequences appeared to have
homology to known RNA elements regulating RNA stability: the poly(A)
tail, the poly(A) signal sequence, or the c-fos
coding region determinant sequence. Only a poly(A) RNA fragment
was shown to shift in an RNA EMSA reaction, and an unlabeled poly(A)
RNA was capable of partial interference with the TNF ARE/Nup475
complex. An ~40-kDa protein has been shown to bind the ARE of the
human interferon-
mRNA (34), similar to the size of Nup475
protein on Western blotting from mammalian cells (39). In that report, the 40-kDa protein-ARE RNA complex was disrupted by either a long poly(A) tail on the interferon-
mRNA or a short poly(A) RNA
competitor with the protein involved having intrinsic poly(A) binding
activity in cross-linking experiments (34). Nup475 is a potential
candidate for that protein and avidly shifts an interferon-
ARE.
Other ARE binding proteins show activity directed toward the AU-rich element and the poly(A) tail: poly(A) binding activity is a feature of
the RNA-stabilizing ARE-binding ELAV proteins (32, 33).
Our findings provide a basis for the report that Nup475 will only bind
efficiently to sequences containing tandem multimers of the sequence
AUUUA, such as c-fos, IL-2, IL-3, TNF, and
granulocyte-macrophage colony-stimulating factor (40), the
binding site for which actually proves to be a central AUUUA core with
a UU contributed from the AUUUA on either side. This is, to our
knowledge, the only AU-rich element-binding protein that selects for a
consensus 9-base pair palindromic ARE, UUAUUUAUU, in RNA SELEX
experiments. The fact that this protein contains two similar
Cys3His RNA binding motifs raises the distinct possibility
that each binds overlapping UUAUU residues and may help understand the
ultra-structural organization of the 3'-UTRs that are a target for its regulation.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grants DK02501 and DK60720 and an American Digestive Health Foundation Industry Research Scholar Award (to M. T. W.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
This manuscript is dedicated to the memory of Daniel Nathans.
To whom correspondence should be addressed: MR-4 Bldg., Rm. 1036, Lane Rd., University of Virginia Health Sciences Center, Charlottesville, VA 22908. Tel.: 434-243-4831; Fax: 434-243-6169; E-mail: mtw3p@virginia.edu.
Published, JBC Papers in Press, September 24, 2002, DOI 10.1074/jbc.M206505200
2 M. Worthington, B. Amann, D. Nathans, and J. Berg, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: ARE, AU-rich element; TNF, tumor necrosis factor; EMSA, electrophoretic mobility shift assay; GST, glutathione S-transferase; UTR, untranslated region.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ross, J.
(1995)
Microbiol. Rev.
59,
423-450 |
| 2. |
Lagnado, C. A.,
Brown, C. Y.,
and Goodall, G. J.
(1994)
Mol. Cell. Biol.
14,
7984-7995 |
| 3. | Zubiaga, A. M., Belasco, J. G., and Greenberg, M. E. (1995) Mol. Cell. Biol. 15, 2219-2230[Abstract] |
| 4. |
Lau, L. F.,
and Nathans, D.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
1182-1186 |
| 5. |
DuBois, R. N.,
McLane, M. W.,
Ryder, K.,
Lau, L. F.,
and Nathans, D.
(1990)
J. Biol. Chem.
265,
19185-19191 |
| 6. |
Lai, W. S.,
Stumpo, D. J.,
and Blackshear, P. J.
(1990)
J. Biol. Chem.
265,
16556-16563 |
| 7. | Ma, Q., and Herschman, H. R. (1991) Oncogene 6, 1277-1278[Medline] [Order article via Infotrieve] |
| 8. | Carballo, E., Gilkeson, G. S., and Blackshear, P. J. (1997) J. Clin. Investig. 100, 986-995[Medline] [Order article via Infotrieve] |
| 9. | Taylor, G. A., Carballo, E., Lee, D. M., Lai, W. S., Thompson, M. J., Patel, D. D., Schenkman, D. I., Gilkeson, G. S., Broxmeyer, H. E., Haynes, B. F., and Blackshear, P. J. (1996) Immunity 4, 445-454[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Lai, W. S.,
Carballo, E.,
Strum, J. R.,
Kennington, E. A.,
Phillips, R. S.,
and Blackshear, P. J.
(1999)
Mol. Cell. Biol.
19,
4311-4323 |
| 11. |
Worthington, M. T.,
Amann, B. T.,
Nathans, D.,
and Berg, J. M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
13754-13759 |
| 12. | Johnson, B. A., Geha, M., and Blackwell, T. K. (2000) Oncogene 19, 1657-1664[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Mahtani, K. R.,
Brook, M.,
Dean, J. L.,
Sully, G.,
Saklatvala, J.,
and Clark, A. R.
(2001)
Mol. Cell. Biol.
21,
6461-6469 |
| 14. | Seidman, C. E., Struhl, K., Sheen, J., and Jensen, T. (1997) in Current Protocols in Molecular Biology (Ausubel, F. M. , Brent, R. , Kingston, R. E. , Moore, D. D. , Seidman, J. G. , Smith, J. A. , and Struhl, K., eds), Vol. 1 , pp. 1.8.1-1.8.10, John Wiley & Sons, New York |
| 15. | Setzer, D. R. (1999) in RNA-Protein Interaction Protocols (Haynes, S. R., ed), Vol. 118 , pp. 115-128, Humana Press, Totowa, NJ |
| 16. |
Sakashita, E.,
and Sakamoto, H.
(1994)
Nucleic Acids Res.
22,
4082-4086 |
| 17. |
Monia, B. P.,
Ecker, D. J.,
Jonnalagadda, S.,
Marsh, J.,
Gotlib, L.,
Butt, T. R.,
and Crooke, S. T.
(1989)
J. Biol. Chem.
264,
4093-4103 |
| 18. |
Taylor, G. A.,
Thompson, M. J.,
Lai, W. S.,
and Blackshear, P. J.
(1995)
J. Biol. Chem.
270,
13341-13347 |
| 19. |
Dale, G. E.,
Schonfeld, H. J.,
Langen, H.,
and Stieger, M.
(1994)
Protein Eng.
7,
925-931 |
| 20. |
Amrein, K. E.,
Takacs, B.,
Stieger, M.,
Molnos, J.,
Flint, N. A.,
and Burn, P.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
1048-1052 |
| 21. |
Pavletich, N. P.,
and Pabo, C. O.
(1991)
Science
252,
809-817 |
| 22. | Andrews, L. G., and Keene, J. D. (1999) in RNA-Protein Interaction Protocols (Haynes, S. R., ed), Vol. 118 , pp. 233-244, Humana Press, Totowa, NJ |
| 23. |
Anant, S.,
and Davidson, N. O.
(2000)
Mol. Cell. Biol.
20,
1982-1992 |
| 24. | Mesner, P. W., Epting, C. L., Hegarty, J. L., and Green, S. H. (1995) J. Neurosci. 15, 7357-7366[Abstract] |
| 25. |
Meisenholder, G. W.,
Martin, S. J.,
Green, D. R.,
Nordberg, J.,
Babior, B. M.,
and Gottlieb, R. A.
(1996)
J. Biol. Chem.
271,
16260-16262 |
| 26. | Taylor, G. A., and Blackshear, P. J. (1995) J. Cell. Physiol. 162, 378-387[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Meerarani, P.,
Ramadass, P.,
Toborek, M.,
Bauer, H. C.,
Bauer, H.,
and Hennig, B.
(2000)
Am. J. Clin. Nutr.
71,
81-87 |
| 28. |
Wilson, G. M.,
Sutphen, K.,
Chuang, K.,
and Brewer, G.
(2001)
J. Biol. Chem.
276,
8695-8704 |
| 29. | Lippard, S. J., and Berg, J. M. (1994) Principles of Bioinorganic Chemistry, pp. 2-6, 21-41, University Science Books, Mill Valley, CA |
| 30. |
Dember, L. M.,
Kim, N. D.,
Liu, K. Q.,
and Anderson, P.
(1996)
J. Biol. Chem.
271,
2783-2788 |
| 31. | Katahira, M., Miyanoiri, Y., Enokizono, Y., Matsuda, G., Nagata, T., Ishikawa, F., and Uesugi, S. (2001) J. Mol. Biol. 311, 973-988[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Abe, R.,
Sakashita, E.,
Yamamoto, K.,
and Sakamoto, H.
(1996)
Nucleic Acids Res.
24,
4895-4901 |
| 33. |
Ma, W. J.,
Chung, S.,
and Furneaux, H.
(1997)
Nucleic Acids Res.
25,
3564-3569 |
| 34. |
Grafi, G.,
Sela, I.,
and Galili, G.
(1993)
Mol. Cell. Biol.
13,
3487-3493 |
| 35. | Driessen, C., Hirv, K., Kirchner, H., and Rink, L. (1995) Immunology 84, 272-277[Medline] [Order article via Infotrieve] |
| 36. |
Caput, D.,
Beutler, B.,
Hartog, K.,
Thayer, R.,
Brown-Shimer, S.,
and Cerami, A.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
1670-1674 |
| 37. |
Lanahan, A.,
Williams, J. B.,
Sanders, L. K.,
and Nathans, D.
(1992)
Mol. Cell. Biol.
12,
3919-3929 |
| 38. |
Meijlink, F.,
Curran, T.,
Miller, A. D.,
and Verma, I. M.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
4987-4991 |
| 39. |
Johnson, B. A.,
Stehn, J. R.,
Yaffe, M. B.,
and Blackwell, T. K.
(2002)
J. Biol. Chem.
277,
18029-18036 |
| 40. |
Raghavan, A.,
Robison, R. L.,
McNabb, J.,
Miller, C. R.,
Williams, D. A.,
and Bohjanen, P. R.
(2001)
J. Biol. Chem.
276,
47958-47965 |
This article has been cited by other articles:
![]() |
F. T. Ishmael, X. Fang, M. R. Galdiero, U. Atasoy, W. F. C. Rigby, M. Gorospe, C. Cheadle, and C. Stellato Role of the RNA-Binding Protein Tristetraprolin in Glucocorticoid-Mediated Gene Regulation J. Immunol., June 15, 2008; 180(12): 8342 - 8353. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Emmons, W.H. D. Townley-Tilson, K. M. Deleault, S. J. Skinner, R. H. Gross, M. L. Whitfield, and S. A. Brooks Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation RNA, May 1, 2008; 14(5): 888 - 902. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Datta, R. Biswas, M. Novotny, P. G. Pavicic Jr., T. Herjan, P. Mandal, and T. A. Hamilton Tristetraprolin Regulates CXCL1 (KC) mRNA Stability J. Immunol., February 15, 2008; 180(4): 2545 - 2552. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Rowlett, C. A. Chrestensen, M. Nyce, M. G. Harp, J. W. Pelo, F. Cominelli, P. B. Ernst, T. T. Pizarro, T. W. Sturgill, and M. T. Worthington MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G452 - G459. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Frasca, A. M. Landin, J. P. Alvarez, P. J. Blackshear, R. L. Riley, and B. B. Blomberg Tristetraprolin, a Negative Regulator of mRNA Stability, Is Increased in Old B Cells and Is Involved in the Degradation of E47 mRNA J. Immunol., July 15, 2007; 179(2): 918 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Lai, J. S. Parker, S. F. Grissom, D. J. Stumpo, and P. J. Blackshear Novel mRNA Targets for Tristetraprolin (TTP) Identified by Global Analysis of Stabilized Transcripts in TTP-Deficient Fibroblasts Mol. Cell. Biol., December 15, 2006; 26(24): 9196 - 9208. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Kritikou, S. Milstein, P.-O. Vidalain, G. Lettre, E. Bogan, K. Doukoumetzidis, P. Gray, T. G. Chappell, M. Vidal, and M. O. Hengartner C. elegans GLA-3 is a novel component of the MAP kinase MPK-1 signaling pathway required for germ cell survival. Genes & Dev., August 15, 2006; 20(16): 2279 - 2292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brook, C. R. Tchen, T. Santalucia, J. McIlrath, J. S. C. Arthur, J. Saklatvala, and A. R. Clark Posttranslational Regulation of Tristetraprolin Subcellular Localization and Protein Stability by p38 Mitogen-Activated Protein Kinase and Extracellular Signal-Regulated Kinase Pathways. Mol. Cell. Biol., March 1, 2006; 26(6): 2408 - 2418. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Wesselkamper, S. A. McDowell, M. Medvedovic, T. P. Dalton, H. S. Deshmukh, M. A. Sartor, L. M. Case, L. N. Henning, M. T. Borchers, C. R. Tomlinson, et al. The Role of Metallothionein in the Pathogenesis of Acute Lung Injury Am. J. Respir. Cell Mol. Biol., January 1, 2006; 34(1): 73 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Lai, D. M. Carrick, and P. J. Blackshear Influence of Nonameric AU-rich Tristetraprolin-binding Sites on mRNA Deadenylation and Turnover J. Biol. Chem., October 7, 2005; 280(40): 34365 - 34377. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Esclatine, B. Taddeo, and B. Roizman Herpes Simplex Virus 1 Induces Cytoplasmic Accumulation of TIA-1/TIAR and both Synthesis and Cytoplasmic Accumulation of Tristetraprolin, Two Cellular Proteins That Bind and Destabilize AU-Rich RNAs J. Virol., August 15, 2004; 78(16): 8582 - 8592. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Tchen, M. Brook, J. Saklatvala, and A. R. Clark The Stability of Tristetraprolin mRNA Is Regulated by Mitogen-activated Protein Kinase p38 and by Tristetraprolin Itself J. Biol. Chem., July 30, 2004; 279(31): 32393 - 32400. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Y. Brewer, J. Malicka, P. J. Blackshear, and G. M. Wilson RNA Sequence Elements Required for High Affinity Binding by the Zinc Finger Domain of Tristetraprolin: CONFORMATIONAL CHANGES COUPLED TO THE BIPARTITE NATURE OF AU-RICH mRNA-DESTABILIZING MOTIFS J. Biol. Chem., July 2, 2004; 279(27): 27870 - 27877. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Brooks, J. E. Connolly, and W. F. C. Rigby The Role of mRNA Turnover in the Regulation of Tristetraprolin Expression: Evidence for an Extracellular Signal-Regulated Kinase-Specific, AU-Rich Element-Dependent, Autoregulatory Pathway J. Immunol., June 15, 2004; 172(12): 7263 - 7271. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cao, J. S. Tuttle, and P. J. Blackshear Immunological Characterization of Tristetraprolin as a Low Abundance, Inducible, Stable Cytosolic Protein J. Biol. Chem., May 14, 2004; 279(20): 21489 - 21499. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Chrestensen, M. J. Schroeder, J. Shabanowitz, D. F. Hunt, J. W. Pelo, M. T. Worthington, and T. W. Sturgill MAPKAP Kinase 2 Phosphorylates Tristetraprolin on in Vivo Sites Including Ser178, a Site Required for 14-3-3 Binding J. Biol. Chem., March 12, 2004; 279(11): 10176 - 10184. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Park-Lee, S. Kim, and I. A. Laird-Offringa Characterization of the Interaction between Neuronal RNA-binding Protein HuD and AU-rich RNA J. Biol. Chem., October 10, 2003; 278(41): 39801 - 39808. |